Qiagen N.V. (QGEN) Operating Expenses (2009 - 2026)

On a TTM basis, Qiagen's Operating Expenses came in at $861.09 million as of Jun 30, 2026, up 5.5% year-over-year; for the year ended Dec 31, 2025, it was $833.64 million, down 4.1% from the prior year.

• Annual Operating Expenses has a five-year compound annual growth rate of -0.3% (years ended Dec 2020 to Dec 2025).
• Across earlier years, Operating Expenses came in at $869.64 million in the year ended Dec 31, 2024 (+5.6%), $823.75 million in the year ended Dec 31, 2023 (-3.4%), $853.1 million in the year ended Dec 31, 2022 (+3.9%) and $820.74 million in the year ended Dec 31, 2021 (-3.0%).
• Quarterly Operating Expenses has ranged from $193.33 million in the quarter ended Mar 31, 2025 to $263.2 million in the quarter ended Jun 30, 2024 over the past five years.
• On a year-over-year basis, Operating Expenses rose in four of the last eight quarters, with growth averaging 0.5%.
• Peak year-over-year performance for Operating Expenses in the last five years was growth of 27.3% in the quarter ended Jun 30, 2024, against a decline of 25.7% in the quarter ended Sep 30, 2021 at the low end.
• Per Business Quant, the preceding three quarters came in at $225.18 million (quarter ended Mar 31, 2026), $225.83 million (quarter ended Dec 31, 2025) and $202.1 million (quarter ended Sep 30, 2025).